Knight Therapeutics Inc. (GUD:CA) Q1 2026 Earnings Call Transcript

May 07, 2026 12:41:24 pm

Source: SeekingAlpha

2026-05-07 12:41:24 ET

Knight Therapeutics Inc. (GUD:CA) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT

Company Participants

Samira Sakhia - President, CEO & Director
Arvind Utchanah - Chief Financial Officer
Amal Khouri - Chief Business Officer
...

For further details see:

Knight Therapeutics Inc.

-4.46% G/L:

$5.57 Last:

163,115 Volume:

$5.83 Open:

June 05, 2026 06:00:00 pm

May 28, 2026 07:30:00 am

May 27, 2026 06:00:00 pm

May 12, 2026 06:30:00 am

Market Cap $0

Float N/A

Insiders Ownership N/A

Institutions

Short Percent N/A

Industry

Sector

Website

Country

City